ClinicalTrials.govpublic full text
JAK2V617F Mutated Endothelium Has a Stem Cell Potential in Primary Myelofibrosis: a New Disease Ontogenesis for Chronic Myeloproliferative Disorders
primary myelofibrosids, primary myelofibrosis, endothelial cells, jak2v617f mutation, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 980098
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.